Pursuing B.Sc, B.Tech, B.Pharma Microbiology, Biotechnology any branch of Life Sciences; M.Sc, M.Tech, M.Pharm Microbiology, Biotechnology any branch of Life Sciences.
Deciphering the contribution of proestrous-estrous transition to seizure susceptibility in drug resistant epilepsy pathologies. Masters degree in Medical Biophysics, Biochemistry, Zoology, Neuroscience, Biomedical Sciences or any other branch of Life Sciences or M.Pharm Pharmacology.
Post Graduate Degree in Life Sciences Biotechnology, Biochemistry, Microbiology, Immunology, etc. with 2 years duration and NET, GATE qualification along with 2 years of research experience after Post-graduation in any of following relevant field
Masters or Ph.D. in Biotechnology, Genomic Science, Biochemistry, Bioinformatics, Biomedical, Bioprocessing with a strong technical knowledge in the respective core domain and passion for life science-related industry segments.
Master Degree in Botany or Zoology or Microbiology or Biotechnology or Biochemistry or Physical Anthropology or Genetics or Forensic Science with Botany or Zoology as one of the subjects during all the three years of bachelor of Science from a recognised University or Institute.
M.Pharm. or M.Sc. Life Sciences including Biotechnology with two years research experience Research experience in bioevaluation of plant drugs and formulation
Project titled Advance Center for Clinical Evaluation of Diagnostics of National Importance. Three years Graduate in Biochemistry, Biotechnology, Life Science from recognized university plus Three-year experience Or PG in relevant subject, field from recognized university, Institute
PhD with 3 years experience in Biological Science, Biotechnology, Biochemistry, Bioengineering, Pharmaceutical Technology or any branch of Life Sciences Relevant to essential criteria.
Conduct preliminary review of laboratory results relative to established protocol-specific reference range guidelines, using relevant clinical laboratory experience and compares current results with prior laboratory values to evaluate or note clinically significant increases, decreases and contacts the investigator site for pertinent additional clinical contact for distribution to project team